The Technical Analyst
Select Language :
Immunovant Inc [IMVT]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Immunovant Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

Immunovant Inc is listed at the  Exchange

-0.65% $32.31

America/New_York / 28 mar 2024 @ 16:00


Immunovant Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 4 694.42 mill
EPS: -1.810
P/E: -17.85
Earnings Date: May 12, 2024
SharesOutstanding: 145.29 mill
Avg Daily Volume: 1.268 mill
RATING 2024-03-28
B
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Neutral
DE: Sell
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -17.85 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-3.04x
Company: PE -17.85 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$3.05
(-90.56%) $-29.26
Date: 2024-03-28
Expected Trading Range (DAY)

$ 30.53 - 34.09

( +/- 5.51%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-02-22 Barnett Eva Renee Sell 2 930 Common Stock
2024-02-22 Levine Mark S. Sell 2 134 Common Stock
2024-02-22 Macias William L. Sell 2 221 Common Stock
2024-02-22 Butchko Julia G. Sell 2 146 Common Stock
2024-02-22 Salzmann Peter Sell 13 454 Common Stock
INSIDER POWER
82.85
Last 99 transactions
Buy: 8 040 481 | Sell: 739 102

Forecast: 16:00 - $32.31

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $32.31
Forecast 2: 16:00 - $32.31
Forecast 3: 16:00 - $32.31
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $32.31 (-0.65% )
Volume 1.182 mill
Avg. Vol. 1.268 mill
% of Avg. Vol 93.22 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Immunovant Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Immunovant Inc

RSI

Intraday RSI14 chart for Immunovant Inc

Last 10 Buy & Sell Signals For IMVT

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$35.22N/AActive
Profile picture for
            Immunovant Inc

IMVT

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company was incorporated in 2018 is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.

Last 10 Buy Signals

Date Signal @
FOLDUSDMar 28 - 16:0320.73
SSVUSDMar 28 - 15:5959.98
SNXUSDMar 28 - 16:00$4.88
ROUTEUSDMar 28 - 15:594.17
FORTHUSDMar 28 - 16:006.60
BCHUSDMar 28 - 16:00$570.06
SFPUSDMar 28 - 15:53$0.773
TAOUSDMar 28 - 15:54545.52
JAZZMar 28 - 15:55$120.49
CTXCUSDMar 28 - 15:54$0.485

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.